Funding for this research was provided by:
Ministry of Education, Culture, Sports, Science and Technology (26293213)
Japan Agency for Medical Research and Development
Received: 25 January 2016
Accepted: 27 May 2016
First Online: 11 June 2016
Conflict of interest
: S. M. owns equity in a gene therapy company (Gene Therapy Research Institution) that commercializes the use of AAV vectors for gene therapy applications. To the extent that the work in this manuscript increases the value of these commercial holdings, S. M. has a conflict of interest.
Free to read: This content has been made available to all.